Shares of BIO-TECHNE Corp (NASDAQ:TECH) have been given a consensus recommendation of “Buy” by the seven brokerages that are presently covering the company. Two analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12 month price target among brokers that have covered the […]
